cetrorelix: Clinical Trials

27 trials of cetrorelix, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 8 unknown, 2 terminated, 1 not yet recruiting. 27 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 427Completed 16, Unknown 8, Terminated 2, Not yet recruiting 1

Follow cetrorelix: new trials by email Literature Review of cetrorelix trials Research Report on cetrorelix

Trials (filtered) newest first · largest first

All 27 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial Comparing Subcutaneous Natural Progesterone (Prolutex) vs. Cetrorelix Acetate for Luteinizing Hormone Surge Suppression in Freeze-All IVF Cycles.
Control Group (A):, Test Group (B): - Assisted Reproductive Techniques
Phase 4Not yet recruitingTrust Fertility Clinic2302026-01-012026-01-20
GnRH Antagonist Pre-treatment in the Early Follicular Phase for Resolution of a Baseline Functional Ovarian Cyst
Cetrorelix Acetate, Ganerelix Acetate - IVF, Ovarian Cysts
Phase 4UnknownAssaf-Harofeh Medical Center152021-05-012021-10-13
Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI
Triptorelin acetate, Cetrorelix, recombinant-FSH or recombinant-FSH + human Menopausal Gonadotropin - In Vitro Fertilization, Intracytoplasmic Sperm Injection
Phase 4CompletedDamascus University502020-08-222023-10-24
Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI
Triptorelin acetate, Cetrorelix, recombinant-FSH or recombinant-FSH + human Menopausal Gonadotropin - In Vitro Fertilization, Infertility
Phase 4CompletedDamascus University502020-08-222023-10-24
Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.
Triptorelin acetate, Cetrorelix, recombinant-FSH or recombinant-FSH + human Menopausal Gonadotropin - In Vitro Fertilization, Intracytoplasmic Sperm Injection
Phase 4CompletedDamascus University502019-12-222023-10-24
Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.
Triptorelin acetate, Cetrorelix, recombinant-FSH or recombinant-FSH + human Menopausal Gonadotropin - In Vitro Fertilization, Intracytoplasmic Sperm Injection
Phase 4CompletedDamascus University502019-12-222023-10-24
Comparison Between Two Different Protocols in Polycystic Ovary Symdrome Women Undergoing Intra-cytoplasmic Injection
Cetrorelix, Leuprolide Acetate - Polycystic Ovary Syndrome
Phase 4UnknownAssiut University1502019-12-072020-03-25
Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS
Gonadotropin, Antagonist - Ovarian Hyperstimulation Syndrome
Phase 4CompletedClinAmygate3002019-07-012019-11-21
Efficacy of Growth Hormone Supplementation With Gonadotrophins in IVF/ICSI for Poor Responders
Growth Hormones Somatropin Recombinant, Placebo saline solution - Infertility, Female
Phase 4CompletedClinAmygate1562018-12-202019-06-24
Frozen Embryo Transfer With GnRH-antagonist Trial
Cetrorelix Acetate - Infertility
Phase 4UnknownUniversity of Oxford3002018-12-132019-04-25
Sex Differences in Myocardial Steatosis Induced Left Ventricular Dysfunction
Estradiol patch, Cetrotide, Fasting - Heart Diseases, Left Ventricular Dysfunction
Phase 4UnknownThe University of Texas at Arlington1002018-09-132024-02-20
Cetrorelix and Ganirelix Flexible Protocol for (IVF)
Ganirelix Acetate, Cetrorelix Acetate - Infertility/Sterility
Phase 4UnknownUniversità degli Studi 'G. d'Annunzio' Chieti e Pescara1002017-11-152018-03-27
Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI
Triptorelin, cetrorelix, Recombinant Follicle Stimulating Hormone - Invitro Fertilization
Phase 4CompletedCairo University2042017-04-212017-11-07
NATural Ovarian Stimulation
Gonal-F®, Cetrotide® - Infertility
Phase 4CompletedAssistance Publique - Hôpitaux de Paris1292017-01-132026-04-03
Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles
Progesterone 25 MG subcutaneous, Micronized progesterone 200 MG, recombinant FSH - Infertility, In Vitro Fertilization
Phase 4TerminatedAndros Day Surgery Clinic602016-12-202020-01-10
Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles
combined oral contaraceptive pills, recombinant FSH, Urinaru gonadotropin - Assisted Reproduction
Phase 4CompletedCairo University1602016-07-202019-07-05
The Comparison of Effect of Four Different Treatment Protocols on IVF Outcomes in Poor Responders Undergoing in Vitro Fertilization.
GnrH Antagonist/letrozole protocol (Cetrotide; serono + Femara; Novartis Pharma AG), microdose flare-up protocol (Lucrin; Abbott + Gonal F, Serono), Antagonist/clomiphene protocol (Cetrotide; serono + Klomen, Kocak pharma) - Poor Responders Undergoing IVF
Phase 4UnknownPınar Özcan Cenksoy1002014-01-012014-01-15
Clomiphene Citrate Plus Gonadotropins and GnRH Antagonist Versus Flexible GnRH Antagonist Protocol Versus Microdose GnRH Agonist Protocol in Poor Responders Undergoing IVF
Clomiphene citrate, Daily FSH and LH plus Cetrorelix, Triptorelin plus daily FSH anh LH - Poor Responders, IVF
Phase 4UnknownBioroma2502014-01-012014-07-28
Assessment of Implantation Potential of Embryos by Time-lapse Technology
recombinant Follicle Stimulating Hormone (rFSH) - Embryo/Fetus Death, Blastocyst Disintegration
Phase 4UnknownBloom IVF and Fertility Centre2002012-12-012013-01-04
Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF)
Menotrophin, Follitrophin alpha, Cetrorelix - Infertility
Phase 4CompletedFerring Pharmaceuticals1242010-10-012014-03-14

Showing 20 of 27. Sign in to see all of them.

Conditions studied

Infertility (12)  ·  Polycystic Ovary Syndrome (3)  ·  Aneuploidy (1)  ·  Embryo Loss (1)  ·  Fasting (1)  ·  Heart Diseases (1)  ·  Infertility, Female (1)  ·  Leiomyoma (1)  ·  Ovarian Cysts (1)  ·  Ovarian Hyperstimulation Syndrome (1)  ·  Stillbirth (1)  ·  Ventricular Dysfunction, Left (1)

Sponsors

Damascus University (4)  ·  Cairo University (2)  ·  ClinAmygate (2)  ·  Andros Day Surgery Clinic (1)  ·  Aristotle University Of Thessaloniki (1)  ·  Assaf-Harofeh Medical Center (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Assiut University (1)  ·  Bart CJM Fauser (1)  ·  Bioroma (1)  ·  Bloom IVF and Fertility Centre (1)  ·  EMD Serono (1)  ·  Ferring Pharmaceuticals (1)  ·  Instituto Valenciano de Infertilidad, IVI VALENCIA (1)  ·  Pınar Özcan Cenksoy (1)

Countries

Egypt (5)  ·  Syria (4)  ·  Italy (3)  ·  United Kingdom (2)  ·  Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  India (1)  ·  Israel (1)  ·  Netherlands (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Abdul Hakim Nattouf, MD, PhD (4)  ·  Marwan Alhalabi, MD, PhD (4)  ·  Sally Kadoura, B Pharm, MD (4)  ·  Adolfo Allegra, MD (1)  ·  Ahmed Maged, MD (1)  ·  Allison M Case, MD FRCSC (1)  ·  Angela R Baerwald, PhD (1)  ·  Eduardo Kelly, MD, MBA (1)  ·  Efstratios Kolibianakis (1)  ·  Eman Elgendy, MD (1)  ·  Gian Mario Tiboni, professor (1)  ·  Hrishikesh D Pai, M.D. (1)

Results publications

PMID 17854523, PMID 18765009, PMID 20637457, PMID 22819187, PMID 23809501, PMID 24129613, PMID 24608161, PMID 24929258, PMID 33011968, PMID 33495008, PMID 34808697

NIH funding

2018 (1)